Genetic research addresses fatalities due to sepsis

September 17, 2012
Genetic research addresses fatalities due to sepsis
Credit: Thinkstock

The genetics of a patient affects the extent of septic shock development and response to therapy. European researchers have identified genes related to sepsis in a study group of more than 2,500 patients in Europe.

Septic shock is a condition that occurs as a result of severe infection to cause a systemic inflammatory response. Fatality from sepsis is high and mainly affects children, the elderly and those with a compromised immune system.

The 'Genetics of sepsis in Europe' (Genosept) project aimed to raise clinical awareness of how a patient's genes may affect important variables like response to treatment and possibility of fatal outcome. To achieve this goal, project scientists defined novel linked to the condition using expression studies. The identified genes were then analysed in relation to predisposition to sepsis-related mortality in European intensive care units.

Genosept scientists have established a system whereby future data can be recorded and therefore pooled in a database for further analysis. An electronic case report form (eCRF) provides details of each patient. Each eCRF is verified for quality and information content.

Most important for genotyping was the identification and evaluation of relevant candidate genes and their markers related to sepsis. Project researchers also developed processes and systems for blood sampling and genotyping tests.

Statistical analysis of the data linked the genetic variants identified with probability of mortality. Furthermore, the analysis pointed to associations between patient genes and phenotype related to sepsis outcomes.

Genosept has built a bridge between genomics and intensive care clinicians involved in this often fatal condition. Application of data means that expensive treatments for may be focused on high-risk patients. Standardisation of protocols also may be translated into the reduction of sepsis-related mortality.

Explore further: Early identification and treatment of septic shock to save lives

Related Stories

Early identification and treatment of septic shock to save lives

June 1, 2012
(Medical Xpress) -- Recognition of severe septic shock early and starting a patient on an effective antibiotic treatment immediately is critical to saving lives, according to an editorial by two Virginia Commonwealth University ...

Combination antibiotic treatment does not result in less organ failure in adults with severe sepsis

May 21, 2012
Frank M. Brunkhorst, M.D., of Friedrich-Schiller University, Jena, Germany, and colleagues conducted a study to compare the effect of the antibiotics moxifloxacin and meropenem with the effect of meropenem monotherapy on ...

Recommended for you

Researchers create skeletal muscle from stem cells

December 18, 2017
UCLA scientists have developed a new strategy to efficiently isolate, mature and transplant skeletal muscle cells created from human pluripotent stem cells, which can produce all cell types of the body. The findings are a ...

Fruit fly breakthrough may help human blindness research

December 18, 2017
For decades, scientists have known that blue light will make fruit flies go blind, but it wasn't clear why. Now, a Purdue University study has found how this light kills cells in the flies' eyes, and that could prove a useful ...

Tiny bilirubin-filled capsules could improve survival of transplanted pancreatic cells

December 18, 2017
By encapsulating bilirubin within tiny nanoparticles, researchers from North Carolina State University and the Ohio State University have improved the survival rates of pancreatic islet cells in vitro in a low-oxygen environment. ...

Tracking effects of a food preservative on the gut microbiome

December 18, 2017
Antimicrobial compounds added to preserve food during storage are believed to be benign and non-toxic to the consumer, but there is "a critical scientific gap in understanding the potential interactions" they may have with ...

Drug found that induces apoptosis in myofibroblasts reducing fibrosis in scleroderma

December 15, 2017
(Medical Xpress)—An international team of researchers has found that the drug navitoclax can induce apoptosis (self-destruction) in myofibroblasts in mice, reducing the spread of fibrosis in scleroderma. In their paper ...

How defeating THOR could bring a hammer down on cancer

December 14, 2017
It turns out Thor, the Norse god of thunder and the Marvel superhero, has special powers when it comes to cancer too.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.